Robert Feezor, MD
Vascular Surgery · Gainesville, FLNPI 1104913110
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Shockwave Medical, Inc at 30.5% of the total. Reporting peaked in 2024 at $31,422 and has fallen 61.3% since, to $12,173 in 2025. Among vascular surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $397.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$27K
- Silk Road Medical, Inc.$19K
- Terumo Medical Corporation$17K
- Boston Scientific$10K
- Cook Incorporated$6K
- Endologix LLC$4K
- plus $6K from 26 others
Across 9 payments — averaging $747.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cook Research Incorporated$7K
What the payments were for
- Consulting fees$29,75033%
- Speaking & faculty fees$42,69048%
- Travel & lodging$8,4509%
- Food & beverage$8,89010%
- Entertainment$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 20 | $27,365 |
| Silk Road Medical, Inc. | 33 | $19,113 |
| Terumo Medical Corporation | 21 | $16,730 |
| Boston Scientific | 18 | $10,288 |
| Cook Incorporated | 3 | $6,215 |
| Endologix LLC | 13 | $3,827 |
| Cook Medical LLC | 18 | $1,236 |
| W. L. Gore & Associates, Inc. | 12 | $811 |
| Cvrx, Inc. | 8 | $713 |
| Siemens Medical Solutions USA, Inc. | 8 | $674 |
| Bolton Medical Inc | 8 | $494 |
| Medtronic(2 entities) | 7 | $339 |
| Philips North America LLC | 8 | $305 |
| Artivion, Inc. | 4 | $220 |
| Penumbra, Inc. | 3 | $211 |
| Cardiovascular Systems Inc. | 4 | $208 |
| Abbott | 5 | $178 |
| Integra Lifesciences Corporation | 5 | $134 |
| Angiodynamics, Inc. | 5 | $134 |
| Smith+Nephew | 7 | $121 |
| Inari Medical, Inc. | 2 | $86 |
| E.r. Squibb & Sons, L.L.C. | 1 | $80 |
| Prytime Medical Devices, Inc. | 1 | $62 |
| Lemaitre Vascular, Inc. | 3 | $46 |
| Contego Medical, Inc | 1 | $43 |
| Inspiremd Ltd | 1 | $31 |
| Johnson & Johnson | 2 | $30 |
| Zimmer Biomet | 1 | $24 |
| Stryker | 1 | $23 |
| Atricure, Inc. | 1 | $21 |
| Abiomed | 1 | $21 |
| Getinge USA Sales, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$45,718
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$27,033
- ENROUTE Transcarotid Stent$17,590
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$17,318
- ANGIO-SEAL$9,000
- Azur CX Detachable$7,487
- Cook Medical Embolization$5,143
- Cook Medical AAA$1,500
- ENHANCE Transcarotid Peripheral Access Kit$1,207
- ENROUTE Transcarotid Stent System$1,093
- ENROUTE 0.014 Guidewire$1,093
- Artis pheno$469
- Barostim Neo System$314
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$132
- Indigo System$131
- Relay Plus$129
- ENDURANT IIS$125
- GENERAL VASCULAR INTERVENTION$119
- GORE EXCLUDER AAA Endoprosthesis$116
- ENROUTE .014 Guidewire$115
How this compares
$89,803 in reported general payments places this provider in the 95th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 115 | $1,408 |
| Atorvastatin Calcium | 30 | $331 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $266 |
| Mupirocin | 27 | $185 |
| Oxycodone Hcl | 23 | $76 |
| Amitriptyline Hcl | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Gainesville
- Michol CooperGainesville$50K
- Samuel TapperStuart$1.3M
- Mariano ArosemenaBradenton$472K
- Manuel Perez IzquierdoOrlando$302K
- Erin MooreJacksonville$300K
- Rajesh MalikNaples$237K
- Charles BaileyTampa$162K
- Joseph WasselleMelbourne$161K
- Joseph RicottaDelray Beach$156K
- Murray ShamesTampa$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.